Skip to main content

Table 4 Model-recommended treatment strategies for achieving EPHP and EOT (after the achievement of EPHP) for high adult burden of infection. Results for low-transmission settings are generated using the ICL model

From: Determining the optimal strategies to achieve elimination of transmission for Schistosoma mansoni

Prevalence in SAC prior to treatment

Model

Model-recommended treatment strategy for achieving EPHP

Model-recommended treatment strategy for achieving EOT after the achievement of EPHP

Low (< 10%)

ICL

75% SAC for 2–4 years

75% SAC and 30% adults for 8–9 years

Moderate (10–50%)

ICL

75% SAC for 5–7 years

75% SAC and 55% adults for 9–10 years

SCHISTOX

75% SAC for 6–8 years

75% SAC and 55% adults for 7 years

High (≥ 50%)

ICL

90% SAC and 45% adults for 5–6 years (baseline prevalence below 60% SAC + 63% adults)

95% SAC and 85% adults for 10 years (baseline prevalence: 71% SAC + 72% adults)

75% SAC and 55% adults for 7–8 years (baseline prevalence below 60% SAC + 63% adults)

85% SAC and 75% adults for 9 years (baseline prevalence: 71% SAC + 72% adults)

SCHISTOX

90% SAC and 45% adults for 4–8 years (baseline prevalence below 76% SAC + 64% adults)

95% SAC and 85% adults for 8 years (baseline prevalence: 79% SAC + 72% adults)

75% SAC and 55% adults for 6–7 years (baseline prevalence below 76% SAC + 64% adults)

85% SAC and 75% adults for 8 years (baseline prevalence: 79% SAC + 72% adults)